What one share of Kodiak Sciences holds
Since its founding in 2009, Kodiak Sciences Inc. (“Kodiak,” the “Company,” “we” or “our”) has developed a new technology platform, the Antibody Biopolymer Conjugate (“ABC”) platform, for retinal medicines. Our goal is to prevent and treat the major causes of blindness by developing and commercializing next-generation therapeutics to address multiple unmet needs on the spectrum of retinal diseases.
Kodiak Sciences’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$4.18 |
|---|---|
| Capex (buildings and equipment) | $0.02 |
| Free cash flow | −$2.76 |
| Cash and investments | $2.00 |
| Book value | $0.97 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | — | −$2.38 | $0.11 | −$2.33 | — | −$5.70 |
| 2017 | — | −$3.72 | $0.03 | −$2.38 | — | −$8.66 |
| 2018 | — | −$2.77 | $0.01 | −$1.94 | — | — |
| 2019 | — | −$1.25 | $0.01 | −$1.05 | — | $7.78 |
| 2020 | — | −$2.91 | $0.08 | −$1.91 | — | $16.84 |
| 2021 | — | −$5.16 | $0.33 | −$3.85 | — | $12.80 |
| 2022 | — | −$6.39 | $0.71 | −$4.66 | — | $8.33 |
| 2023 | — | −$4.97 | $0.79 | −$3.73 | — | $5.06 |
| 2024 | — | −$3.35 | $0.01 | −$2.24 | — | $2.85 |
| 2025 | — | −$4.32 | $0.01 | −$2.57 | — | $2.55 |
Common questions about Kodiak Sciences
How much does one share of Kodiak Sciences earn?
Over the last 12 months, Kodiak Sciences lost $4.18 for each share.
Does Kodiak Sciences pay a dividend?
Kodiak Sciences didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Kodiak Sciences’s book value per share?
Kodiak Sciences’s book value is $0.97 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Kodiak Sciences have?
Each share of Kodiak Sciences has $2.00 of cash and investments, as of June 30, 2026.
What is Kodiak Sciences’s free cash flow per share?
−$2.76 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Kodiak Sciences bought back shares?
Kodiak Sciences’s share count rose about 638% from 2016 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.